135 related articles for article (PubMed ID: 35822673)
1. Drug-level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients.
Kim OH; Shim TS; Jo KW
Transpl Infect Dis; 2022 Aug; 24(4):e13893. PubMed ID: 35822673
[TBL] [Abstract][Full Text] [Related]
2. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
Hickey MD; Quan DJ; Chin-Hong PV; Roberts JP
Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
[TBL] [Abstract][Full Text] [Related]
3. Rifabutin for treating tuberculosis in solid organ transplant recipients: A retrospective observational study and literature review.
Gomila-Grange A; Pérez-Recio S; Camprubí-Ferrer D; Lladó L; Fava A; García-Romero E; Grijota-Camino MD; Sabé N; Santin M
Transpl Infect Dis; 2021 Apr; 23(2):e13471. PubMed ID: 32959494
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
Ha YE; Joo EJ; Park SY; Wi YM; Kang CI; Chung DR; Joh JW; Lee SK; Song JH; Peck KR
Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
[TBL] [Abstract][Full Text] [Related]
5. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations.
Bonatti H; Barroso LF; Sawyer RG; Kotton CN; Sifri CD
Transpl Infect Dis; 2012 Dec; 14(6):635-48. PubMed ID: 22340660
[TBL] [Abstract][Full Text] [Related]
6. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study.
Tabarsi P; Farshidpour M; Marjani M; Baghaei P; Yousefzadeh A; Najafizadeh K; Sharifkashani B; Javanmard P; Mansouri D; Masjedi M; Velayati A
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):6-11. PubMed ID: 25579709
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis.
Wang YC; Salvador NG; Lin CC; Wu CC; Lin TL; Lee WF; Chan YC; Chen CL; Co JS; Encarnacion DD
Biomed J; 2021 Dec; 44(6 Suppl 2):S162-S170. PubMed ID: 35300949
[TBL] [Abstract][Full Text] [Related]
9. An Integrated Clinical and Genetic Prediction Model for Tacrolimus Levels in Pediatric Solid Organ Transplant Recipients.
Min S; Papaz T; Lambert AN; Allen U; Birk P; Blydt-Hansen T; Foster BJ; Grasemann H; Hamiwka L; Litalien C; Ng V; Berka N; Campbell P; Daniel C; Saw CL; Tinckam K; Urschel S; Van Driest SL; Parekh R; Mital S
Transplantation; 2022 Mar; 106(3):597-606. PubMed ID: 33755393
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
[TBL] [Abstract][Full Text] [Related]
11. Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review.
Rezahosseini O; Møller DL; Knudsen AD; Sørensen SS; Perch M; Gustafsson F; Rasmussen A; Ostrowski SR; Nielsen SD
Front Immunol; 2020; 11():567715. PubMed ID: 33178194
[No Abstract] [Full Text] [Related]
12. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective.
Schumacher L; Leino AD; Park JM
Pharmacotherapy; 2021 Jan; 41(1):103-118. PubMed ID: 33131078
[TBL] [Abstract][Full Text] [Related]
13. Determining the conversion ratios for oral versus sublingual administration of tacrolimus in solid organ transplant recipients.
Al Sagheer T; Enderby CY
Clin Transplant; 2019 Oct; 33(10):e13727. PubMed ID: 31587353
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus.
Vondrak K; Parisi F; Dhawan A; Grenda R; Webb NJA; Marks SD; Debray D; Holt RCL; Lachaux A; Kelly D; Kazeem G; Undre N
Clin Transplant; 2019 Oct; 33(10):e13698. PubMed ID: 31436896
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
[TBL] [Abstract][Full Text] [Related]
16. Treating tuberculosis in solid organ transplant recipients.
Sun HY
Curr Opin Infect Dis; 2014 Dec; 27(6):501-5. PubMed ID: 25211360
[TBL] [Abstract][Full Text] [Related]
17. Clinical insights into the role of immunosuppression in solid organ transplant recipients with COVID-19.
Kolonko A; Kuczaj AA; Musialik J; Słabiak-Błaż N; Hrapkowicz T; Przybyłowski P; Więcek A
Pol Arch Intern Med; 2022 Nov; 132(2):. PubMed ID: 34779600
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial infections in solid organ transplant recipients.
Meije Y; Piersimoni C; Torre-Cisneros J; Dilektasli AG; Aguado JM;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():89-101. PubMed ID: 24707957
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.
Lichvar A; Tremblay S; Naik D; Lipscomb J; King E; Vinks AA; Christians U; Alloway RR
Pharmacotherapy; 2019 May; 39(5):564-575. PubMed ID: 30892704
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-Associated Colitis Post-Transplant Is Not Associated with Elevation of Tacrolimus Concentrations.
Bonatti HJR; Sadik KW; Krebs ED; Sifri CD; Pruett TL; Sawyer RG
Surg Infect (Larchmt); 2017; 18(6):689-693. PubMed ID: 28650734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
